Clinical Trial Update: Versartis Trial in Children to Assess Long-Acting Growth Hormone [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for Versartis' long-acting growth hormone in children shows completion of Phase 1/Phase 2 studies for Pediatric Growth Hormone Deficienc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency

Drugs mentioned

• Versartis long-acting growth hormone (growth hormone)

Snippet

Sponsor: Versartis Inc. | Conditions: Pediatric Growth Hormone Deficiency | Phase 1, Phase 2 | Status: COMPLETED